Clinical trial
Clinical and Sociodemographic Characterization of Multiple Myeloma Patients With Symptomatic Relapse and/or Refractory Disease in Spain
NCT03188536 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical and Sociodemographic Characterization of Multiple Myeloma Patients With Symptomatic Relapse and/or Refractory Disease in Spain
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 26, 2017
- Completion date
- January 30, 2019
- Enrollment
- 282 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.